CRNX SEC Comment Letters | Crinetics Pharmaceuticals, Inc.

Crinetics Pharmaceuticals, Inc. SEC Comment Letters

No SEC Comment Letters for CRNX on this site yet.

Source checked: its SEC EDGAR filings (CIK 1658247).